~~<i id='E918726D6A'><strike id='E918726D6A'><tt id='E918726D6A'><pre id='E918726D6A'></pre></tt></strike></i>~~

Home» focus» hotspot

hotspot

author：knowledge 2025-08-13 04:13:12 Page View：954

Neumora, a neuroscience startup founded by VC Arch Venture Partners, hopes to become one of the few biotechs to go public this year.

The company filed paperwork for an IPO with the Securities and Exchange Commission on Friday. It did not state how many shares it plans to sell or at what price.

The biotech had begun planning for an IPO last year, STAT reported in June 2022. It raised $112 million in what would turn out to be a crossover round last October.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： California Joshua trees severely burned in massive wildfire
Next article： Sports medicine is finally prioritizing gender equality

focus

Continuity nursing helped my family in our darkest PICU moments

EssayauthorSarahMcCarthycuddleswithherdaughterMolly.CourtesySarahMcCarthyTheventilatoralarmwokemeat3

Change Healthcare cyberattack affects 25% of CVS/Aetna insurance claims

AdobeSomeofthecountry’sbiggesthealthinsurerssaidTuesdaythatuptoone-quarteroftheirclaimsarerunthrough

The high cost of giving birth even with insurance

AdobeTheburdenofhighhealthcarecostsandmedicaldebtintheU.S.isnosecret.Medicaldebtaffectsoneinfiveadul

Pediatricians' group reaffirms support for gender

Aprotestorwearsatransgenderflagatahearingonbanninggender-affirminghealthcarelegislationinMissouri.AP